RSG
71
3
ADSK
70
2
NWS
66
-3
NSC
60
3
TXT
55
3
AN
58
4
DG
6
2
WDC
47
4
CFG
70
6
SYK
64
-4
NEE
50
-5
HAS
33
3
ORLY
62
2
AXP
71
2
SWK
64
5
BMY
60
2
CL
58
2
EBAY
47
4
AIV
72
2
CSCO
67
4
RSG
71
3
ADSK
70
2
NWS
66
-3
NSC
60
3
TXT
55
3
AN
58
4
DG
6
2
WDC
47
4
CFG
70
6
SYK
64
-4
NEE
50
-5
HAS
33
3
ORLY
62
2
AXP
71
2
SWK
64
5
BMY
60
2
CL
58
2
EBAY
47
4
AIV
72
2
CSCO
67
4
Financhill
Back

Spero Therapeutics Vs. Arbutus Biopharma Industry Stock Comparison

Sell
15

SPRO
Spero Therapeutics

Last Price:
1.18
Seasonality Move:
7.16%
Sell
37

ABUS
Arbutus Biopharma

Last Price:
3.51
Seasonality Move:
24.22%
Sell
15
Spero Therapeutics (SPRO) is a Sell

Is Spero Therapeutics a Buy, Sell or Hold?

  • The current Spero Therapeutics [SPRO] share price is $1.16. The Score for SPRO is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • SPRO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
37
Arbutus Biopharma (ABUS) is a Sell

Is Arbutus Biopharma a Buy, Sell or Hold?

  • The current Arbutus Biopharma [ABUS] share price is $3.51. The Score for ABUS is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • ABUS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SPRO Stock Price Chart

What is Spero Therapeutics's stock price today?

  • The Spero Therapeutics share price today is $1.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SPRO is experiencing selling pressure, which indicates risk of future bearish movement.

ABUS Stock Price Chart

What is Arbutus Biopharma's stock price today?

  • The Arbutus Biopharma share price today is $3.51
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing slight buying pressure.

SPRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 38.15 Sell
Chaikin Money Flow: -217293 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.2 - 1.32) Sell
Bollinger Bands (100): (1.24 - 1.38) Sell

ABUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 34.97 Sell
Chaikin Money Flow: 429896 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.59 - 4.01) Sell
Bollinger Bands (100): (3.58 - 4.12) Sell

SPRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.2 Sell
20-day SMA: 1.25 Sell
50-day SMA: 1.28 Sell
200-day SMA: 1.43 Sell
8-day EMA: 1.2 Sell
20-day EMA: 1.24 Sell
50-day EMA: 1.27 Sell
200-day EMA: 1.38 Sell

ABUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.54 Sell
20-day SMA: 3.74 Sell
50-day SMA: 3.89 Sell
200-day SMA: 3.38 Buy
8-day EMA: 3.55 Sell
20-day EMA: 3.69 Sell
50-day EMA: 3.8 Sell
200-day EMA: 3.43 Buy

Spero Therapeutics Earnings Growth & SPRO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.55 per share, and an increase next year of $0.58 per share.

Arbutus Biopharma Earnings Growth & ABUS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.

Spero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Arbutus Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):